DUBLIN, Ireland & BERWYN, PA — AscellaHealth has announced its participation in the Advanced Therapies Integrates North 2025, set to take place on April 30 at the Usher Institute in Edinburgh. Gillian Molloy, vice president of Market Access at AscellaHealth, will serve as a featured panellist during the “Strength in Numbers” session scheduled from 12:20 PM to 1:00 PM.
With nearly two decades of transatlantic expertise in life sciences, Molloy will bring a wealth of knowledge to the discussion, focusing on collaboration in the development and market access of advanced therapy medicinal products (ATMPs). Her insights will address key challenges in the regulatory and commercial pathways of ATMPs, offering strategies to foster effective partnerships and accelerate innovation.
“These are exciting times for advancing ATMP clinical development, and this meeting serves as a pivotal platform for exploring faster, smarter and more efficient development pathways,” said Molloy, emphasizing the critical role of collaboration in delivering life-changing treatments to patients worldwide.
AscellaHealth’s contributions extend beyond the conference. Molloy and Alexis Moss, the company’s director of business development, are scheduled to participate in upcoming virtual roundtable webinars hosted by the Life Science Access Academy this June. Highlights include Moss’s session, “Homecare: An NHS Update” on June 20, and Molloy’s “Gene Therapy: Rhetoric vs Reality” on June 27.
Moss and Molloy’s extensive experience in strategic innovation and patient-centered solutions underscore AscellaHealth’s ongoing commitment to improving outcomes for patients and navigating the complexities of ATMP development.
Through active participation in global events and continuous knowledge-sharing, AscellaHealth remains at the forefront of fostering advancements in healthcare for rare and chronic diseases.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.